Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Oct 1;100(7):1685–1692. doi: 10.1172/JCI119693

Glucose-specific regulation of aldose reductase in capan-1 human pancreatic duct cells In vitro.

J V Busik 1, S R Hootman 1, C A Greenidge 1, D N Henry 1
PMCID: PMC508351  PMID: 9312166

Abstract

Impaired pancreatic duct secretion is frequently observed in insulin-dependent diabetes mellitus (IDDM), although the cellular mechanism(s) of dysfunction remains unknown. Studies in other tissues have suggested that a hyperglycemia-induced decrease in Na, K-ATPase activity could contribute to the metabolic complications of IDDM and that increased polyol metabolism is involved in this response. The present studies examined the effects of glucose on Na, K-ATPase activity and on expression and activity of aldose reductase (AR), a primary enzyme of polyol metabolism, in Capan-1 human pancreatic duct cells. Increasing medium glucose from 5.5 to 22 mM caused a 29% decrease in Na,K-ATPase activity. The decrease was corrected by 100 microM sorbinil, a specific AR inhibitor. Increasing glucose from 5.5 to 110 mM also resulted in concentration-dependent increases in AR mRNA and enzyme activity that could be resolved into two components, one that was glucose specific and observed at pathophysiological concentrations (< 55 mM) and a second that was osmotically induced at high concentrations (> 55 mM) and which was not glucose specific. The present study demonstrates that pathophysiological levels of glucose specifically activate polyol metabolism with a consequent decrease in Na,K-ATPase activity in pancreatic duct epithelial cells, and that this response to hyperglycemia could contribute to decreased pancreatic secretion observed in IDDM. This is the first report of AR regulation in the pancreatic duct epithelium.

Full Text

The Full Text of this article is available as a PDF (441.2 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Becq F., Fanjul M., Mahieu I., Berger Z., Gola M., Hollande E. Anion channels in a human pancreatic cancer cell line (Capan-1) of ductal origin. Pflugers Arch. 1992 Jan;420(1):46–53. doi: 10.1007/BF00378640. [DOI] [PubMed] [Google Scholar]
  2. Becq F., Fanjul M., Merten M., Figarella C., Hollande E., Gola M. Possible regulation of CFTR-chloride channels by membrane-bound phosphatases in pancreatic duct cells. FEBS Lett. 1993 Aug 2;327(3):337–342. doi: 10.1016/0014-5793(93)81016-s. [DOI] [PubMed] [Google Scholar]
  3. Becq F., Hollande E., Gola M. Phosphorylation-regulated low-conductance Cl- channels in a human pancreatic duct cell line. Pflugers Arch. 1993 Oct;425(1-2):1–8. doi: 10.1007/BF00374496. [DOI] [PubMed] [Google Scholar]
  4. Bertorello A. M., Aperia A., Walaas S. I., Nairn A. C., Greengard P. Phosphorylation of the catalytic subunit of Na+,K(+)-ATPase inhibits the activity of the enzyme. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11359–11362. doi: 10.1073/pnas.88.24.11359. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Borghini I., Geering K., Gjinovci A., Wollheim C. B., Pralong W. F. In vivo phosphorylation of the Na,K-ATPase alpha subunit in sciatic nerves of control and diabetic rats: effects of protein kinase modulators. Proc Natl Acad Sci U S A. 1994 Jun 21;91(13):6211–6215. doi: 10.1073/pnas.91.13.6211. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bradford M. M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976 May 7;72:248–254. doi: 10.1016/0003-2697(76)90527-3. [DOI] [PubMed] [Google Scholar]
  7. Burg M. B. Molecular basis for osmoregulation of organic osmolytes in renal medullary cells. J Exp Zool. 1994 Feb 1;268(2):171–175. doi: 10.1002/jez.1402680216. [DOI] [PubMed] [Google Scholar]
  8. CHEY W. Y., SHAY H., SHUMAN C. R. EXTERNAL PANCREATIC SECRETION IN DIABETES MELLITUS. Ann Intern Med. 1963 Dec;59:812–821. doi: 10.7326/0003-4819-59-6-812. [DOI] [PubMed] [Google Scholar]
  9. Church G. M., Gilbert W. Genomic sequencing. Proc Natl Acad Sci U S A. 1984 Apr;81(7):1991–1995. doi: 10.1073/pnas.81.7.1991. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Cohen M. P., Dasmahapatra A., Shapiro E. Reduced glomerular sodium/potassium adenosine triphosphatase activity in acute streptozocin diabetes and its prevention by oral sorbinil. Diabetes. 1985 Nov;34(11):1071–1074. doi: 10.2337/diab.34.11.1071. [DOI] [PubMed] [Google Scholar]
  11. Domschke W., Tympner F., Domschke S., Demling L. Exocrine pancreatic function in juvenile diabetics. Am J Dig Dis. 1975 Apr;20(4):309–312. doi: 10.1007/BF01237787. [DOI] [PubMed] [Google Scholar]
  12. Dorin R. I., Shah V. O., Kaplan D. L., Vela B. S., Zager P. G. Regulation of aldose reductase gene expression in renal cortex and medulla of rats. Diabetologia. 1995 Jan;38(1):46–54. doi: 10.1007/BF02369352. [DOI] [PubMed] [Google Scholar]
  13. Fanjul M., Hollande E. Morphogenesis of "duct-like" structures in three-dimensional cultures of human cancerous pancreatic duct cells (Capan-1). In Vitro Cell Dev Biol Anim. 1993 Jul;29A(7):574–584. doi: 10.1007/BF02634151. [DOI] [PubMed] [Google Scholar]
  14. Ferraris J. D., Williams C. K., Jung K. Y., Bedford J. J., Burg M. B., García-Pérez A. ORE, a eukaryotic minimal essential osmotic response element. The aldose reductase gene in hyperosmotic stress. J Biol Chem. 1996 Aug 2;271(31):18318–18321. doi: 10.1074/jbc.271.31.18318. [DOI] [PubMed] [Google Scholar]
  15. Frier B. M., Faber O. K., Binder C., Elliot H. L. The effect of residual insulin secretion on exocrine pancreatic function in juvenile-onset diabetes mellitus. Diabetologia. 1978 May;14(5):301–304. doi: 10.1007/BF01223020. [DOI] [PubMed] [Google Scholar]
  16. Frier B. M., Saunders J. H., Wormsley K. G., Bouchier I. A. Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut. 1976 Sep;17(9):685–691. doi: 10.1136/gut.17.9.685. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Ghahary A., Luo J. M., Gong Y. W., Chakrabarti S., Sima A. A., Murphy L. J. Increased renal aldose reductase activity, immunoreactivity, and mRNA in streptozocin-induced diabetic rats. Diabetes. 1989 Aug;38(8):1067–1071. doi: 10.2337/diab.38.8.1067. [DOI] [PubMed] [Google Scholar]
  18. Greene D. A., Lattimer S. A. Impaired rat sciatic nerve sodium-potassium adenosine triphosphatase in acute streptozocin diabetes and its correction by dietary myo-inositol supplementation. J Clin Invest. 1983 Sep;72(3):1058–1063. doi: 10.1172/JCI111030. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Greene D. A., Lattimer S. A., Sima A. A. Sorbitol, phosphoinositides, and sodium-potassium-ATPase in the pathogenesis of diabetic complications. N Engl J Med. 1987 Mar 5;316(10):599–606. doi: 10.1056/NEJM198703053161007. [DOI] [PubMed] [Google Scholar]
  20. Haneda M., Kikkawa R., Arimura T., Ebata K., Togawa M., Maeda S., Sawada T., Horide N., Shigeta Y. Glucose inhibits myo-inositol uptake and reduces myo-inositol content in cultured rat glomerular mesangial cells. Metabolism. 1990 Jan;39(1):40–45. doi: 10.1016/0026-0495(90)90145-3. [DOI] [PubMed] [Google Scholar]
  21. Henry D. N., Del Monte M., Greene D. A., Killen P. D. Altered aldose reductase gene regulation in cultured human retinal pigment epithelial cells. J Clin Invest. 1993 Aug;92(2):617–623. doi: 10.1172/JCI116629. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hermenegildo C., Felipo V., Miñana M. D., Romero F. J., Grisolía S. Sustained recovery of Na(+)-K(+)-ATPase activity in sciatic nerve of diabetic mice by administration of H7 or calphostin C, inhibitors of PKC. Diabetes. 1993 Feb;42(2):257–262. doi: 10.2337/diab.42.2.257. [DOI] [PubMed] [Google Scholar]
  23. Hieber V., Siegel G. J., Desmond T., Liu J. L., Ernst S. A. Na,K-ATPase: comparison of the cellular localization of alpha-subunit mRNA and polypeptide in mouse cerebellum, retina, and kidney. J Neurosci Res. 1989 May;23(1):9–20. doi: 10.1002/jnr.490230103. [DOI] [PubMed] [Google Scholar]
  24. Hootman S. R., de Ondarza J. Overview of pancreatic duct physiology and pathophysiology. Digestion. 1993;54(6):323–330. doi: 10.1159/000201051. [DOI] [PubMed] [Google Scholar]
  25. Ishii H., Jirousek M. R., Koya D., Takagi C., Xia P., Clermont A., Bursell S. E., Kern T. S., Ballas L. M., Heath W. F. Amelioration of vascular dysfunctions in diabetic rats by an oral PKC beta inhibitor. Science. 1996 May 3;272(5262):728–731. doi: 10.1126/science.272.5262.728. [DOI] [PubMed] [Google Scholar]
  26. KINOSHITA J. H. PATHWAYS OF GLUCOSE METABOLISM IN THE LENS. Invest Ophthalmol. 1965 Aug;4:619–628. [PubMed] [Google Scholar]
  27. Kador P. F., Carper D., Kinoshita J. H. Rapid purification of human placental aldose reductase. Anal Biochem. 1981 Jun;114(1):53–58. doi: 10.1016/0003-2697(81)90450-4. [DOI] [PubMed] [Google Scholar]
  28. Kador P. F., Kinoshita J. H., Tung W. H., Chylack L. T., Jr Differences in the susceptibility of various aldose reductases to inhibition. II. Invest Ophthalmol Vis Sci. 1980 Aug;19(8):980–982. [PubMed] [Google Scholar]
  29. Kim J., Kyriazi H., Greene D. A. Normalization of Na(+)-K(+)-ATPase activity in isolated membrane fraction from sciatic nerves of streptozocin-induced diabetic rats by dietary myo-inositol supplementation in vivo or protein kinase C agonists in vitro. Diabetes. 1991 May;40(5):558–567. doi: 10.2337/diab.40.5.558. [DOI] [PubMed] [Google Scholar]
  30. Lowndes J. M., Hokin-Neaverson M., Bertics P. J. Kinetics of phosphorylation of Na+/K(+)-ATPase by protein kinase C. Biochim Biophys Acta. 1990 Apr 9;1052(1):143–151. doi: 10.1016/0167-4889(90)90069-p. [DOI] [PubMed] [Google Scholar]
  31. MacGregor L. C., Matschinsky F. M. Experimental diabetes mellitus impairs the function of the retinal pigmented epithelium. Metabolism. 1986 Apr;35(4 Suppl 1):28–34. doi: 10.1016/0026-0495(86)90184-8. [DOI] [PubMed] [Google Scholar]
  32. Martial S., Price S. R., Sands J. M. Regulation of aldose reductase, sorbitol dehydrogenase, and taurine cotransporter mRNA in rat medulla. J Am Soc Nephrol. 1995 May;5(11):1971–1978. doi: 10.1681/ASN.V5111971. [DOI] [PubMed] [Google Scholar]
  33. Middleton J. P., Khan W. A., Collinsworth G., Hannun Y. A., Medford R. M. Heterogeneity of protein kinase C-mediated rapid regulation of Na/K-ATPase in kidney epithelial cells. J Biol Chem. 1993 Jul 25;268(21):15958–15964. [PubMed] [Google Scholar]
  34. Nishida K., Ohara T., Johnson J., Wallner J. S., Wilk J., Sherman N., Kawakami K., Sussman K. E., Draznin B. Na+/K(+)-ATPase activity and its alpha II subunit gene expression in rat skeletal muscle: influence of diabetes, fasting, and refeeding. Metabolism. 1992 Jan;41(1):56–63. doi: 10.1016/0026-0495(92)90191-c. [DOI] [PubMed] [Google Scholar]
  35. Nishizuka Y. The Albert Lasker Medical Awards. The family of protein kinase C for signal transduction. JAMA. 1989 Oct 6;262(13):1826–1833. [PubMed] [Google Scholar]
  36. Peterson G. L. A simplified method for analysis of inorganic phosphate in the presence of interfering substances. Anal Biochem. 1978 Jan;84(1):164–172. doi: 10.1016/0003-2697(78)90495-5. [DOI] [PubMed] [Google Scholar]
  37. Porte D., Jr, Schwartz M. W. Diabetes complications: why is glucose potentially toxic? Science. 1996 May 3;272(5262):699–700. doi: 10.1126/science.272.5262.699. [DOI] [PubMed] [Google Scholar]
  38. Sands J. M., Terada Y., Bernard L. M., Knepper M. A. Aldose reductase activities in microdissected rat renal tubule segments. Am J Physiol. 1989 Apr;256(4 Pt 2):F563–F569. doi: 10.1152/ajprenal.1989.256.4.F563. [DOI] [PubMed] [Google Scholar]
  39. Shindo H., Thomas T. P., Larkin D. D., Karihaloo A. K., Inada H., Onaya T., Stevens M. J., Greene D. A. Modulation of basal nitric oxide-dependent cyclic-GMP production by ambient glucose, myo-inositol, and protein kinase C in SH-SY5Y human neuroblastoma cells. J Clin Invest. 1996 Feb 1;97(3):736–745. doi: 10.1172/JCI118472. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. Sima A. A., Prashar A., Zhang W. X., Chakrabarti S., Greene D. A. Preventive effect of long-term aldose reductase inhibition (ponalrestat) on nerve conduction and sural nerve structure in the spontaneously diabetic Bio-Breeding rat. J Clin Invest. 1990 May;85(5):1410–1420. doi: 10.1172/JCI114585. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Simmons D. A., Winegrad A. I. Mechanism of glucose-induced (Na+, K+)-ATPase inhibition in aortic wall of rabbits. Diabetologia. 1989 Jul;32(7):402–408. doi: 10.1007/BF00271258. [DOI] [PubMed] [Google Scholar]
  42. Tilton R. G., Baier L. D., Harlow J. E., Smith S. R., Ostrow E., Williamson J. R. Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+. Kidney Int. 1992 Apr;41(4):778–788. doi: 10.1038/ki.1992.121. [DOI] [PubMed] [Google Scholar]
  43. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Uchida S., Garcia-Perez A., Murphy H., Burg M. Signal for induction of aldose reductase in renal medullary cells by high external NaCl. Am J Physiol. 1989 Mar;256(3 Pt 1):C614–C620. doi: 10.1152/ajpcell.1989.256.3.C614. [DOI] [PubMed] [Google Scholar]
  45. Vinores S. A., Campochiaro P. A., Williams E. H., May E. E., Green W. R., Sorenson R. L. Aldose reductase expression in human diabetic retina and retinal pigment epithelium. Diabetes. 1988 Dec;37(12):1658–1664. doi: 10.2337/diab.37.12.1658. [DOI] [PubMed] [Google Scholar]
  46. Wolf B. A., Williamson J. R., Easom R. A., Chang K., Sherman W. R., Turk J. Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest. 1991 Jan;87(1):31–38. doi: 10.1172/JCI114988. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Xia P., Kramer R. M., King G. L. Identification of the mechanism for the inhibition of Na+,K(+)-adenosine triphosphatase by hyperglycemia involving activation of protein kinase C and cytosolic phospholipase A2. J Clin Invest. 1995 Aug;96(2):733–740. doi: 10.1172/JCI118117. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES